• By ICR Secretariat
  • Posted Thursday, April 7, 2022

Yet another gene therapy developer turns to layoffs


  • A Dallas-based gene therapy developer with a lengthy list of research projects has decided to prioritize two moving forward and, in doing so, will reduce its workforce by approximately 35%, joining a series of other companies in the space that have turned to layoffs in recent months.